Member Bibliography/Bibliografía de Miembros
Esta página presenta todas las publicaciones personales que los miembros de CienciaPR han subido a sus perfiles. También puedes ver todos los autores en esta colección de publicaciones o todas las palabras claves contenidas en la colección.
,
«ATP11B mediates platinum resistance in ovarian cancer.», J Clin Invest, vol. 123, n.º 5, pp. 2119-30, 2013.
, «Src activation by β-adrenoreceptors is a key switch for tumour metastasis.», Nat Commun, vol. 4, p. 1403, 2013.
, «Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.», Gastroenterology, vol. 141, n.º 5, pp. 1728-37, 2011.
, «Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.», PLoS One, vol. 6, n.º 7, p. e21121, 2011.
, «Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.», J Natl Cancer Inst, vol. 103, n.º 21, pp. 1596-612, 2011.
, «Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.», Clin Cancer Res, vol. 17, n.º 11, pp. 3716-26, 2011.
, «Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.», Clin Cancer Res, vol. 17, n.º 8, pp. 2250-9, 2011.
, «Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.», J Clin Invest, vol. 120, n.º 5, pp. 1515-23, 2010.
, «c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.», Clin Cancer Res, vol. 16, n.º 1, pp. 184-94, 2010.
, «Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma.», Mol Cancer Ther, vol. 9, n.º 8, pp. 2377-88, 2010.
, «SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.», Cancer Cell, vol. 18, n.º 2, pp. 109-21, 2010.
, «Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.», J Biol Chem, vol. 285, n.º 46, pp. 35462-70, 2010.
, «Sustained small interfering RNA delivery by mesoporous silicon particles.», Cancer Res, vol. 70, n.º 9, pp. 3687-96, 2010.
, «The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment.», PLoS One, vol. 4, n.º 10, p. e7502, 2009.
, «Dual targeting of EphA2 and FAK in ovarian carcinoma.», Cancer Biol Ther, vol. 8, n.º 11, pp. 1027-34, 2009.
, «Therapeutic Targeting of ATP7B in Ovarian Carcinoma.», Clin Cancer Res, vol. 15, n.º 11, pp. 3770-80, 2009.
, «Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.», Cancer Res, vol. 68, n.º 14, pp. 5849-58, 2008.
, «Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.», Clin Cancer Res, vol. 14, n.º 24, pp. 8143-51, 2008.
, «Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.», Cancer Res, vol. 68, n.º 21, pp. 9078-86, 2008.
,